• Episode 24 - Amy Chesire & Greg Suter

  • May 28 2021
  • Durée: 52 min
  • Podcast

Episode 24 - Amy Chesire & Greg Suter

Écouter gratuitement

Voir les détails du balado

  • Résumé

  • Amy Chesire (University of Rochester) and Greg Suter (Hereditary Neurological Disease Centre) are long-time site coordinators for clinical trials in Huntington's disease. On this episode of the HD Insights Podcast, we spoke with both about their history of working with clinical study participants and their current experience with participants on the KINECT-HD study.

    KINECT-HD is a Phase 3, randomized, double-blind, placebo-controlled study investigating valbenazine for treatment of chorea in Huntington disease. The study is being conducted at sites across the U.S. and Canada. Additional information about the study can be found at www.KINECT-HD.org.

    Voir plus Voir moins
Science
Voir plus Voir moins
activate_Holiday_promo_in_buybox_DT_T2
activate_samplebutton_t1

Ce que les auditeurs disent de Episode 24 - Amy Chesire & Greg Suter

Moyenne des évaluations de clients

Évaluations – Cliquez sur les onglets pour changer la source des évaluations.

Évaluations sur Audible.ca

Évaluations sur Amazon.ca
Il n'y a pas encore de critiques pour ce titre.